AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Specific Kinase Inhibitory Peptides for Use in Treatment of Cancer and Inflammatory Disorders

IP Title

Inhibitors of Autophosphorylation Protein Kinases

Detailed Technology Description

None

Supplementary Information

Inventor: ZHANG, Meiyun
Priority Number: WO2011066721A1
IPC Current: C07K001628 | A61K003900 | A61K0039395 | C12N000518 | C12N001513
Assignee Applicant: The University of Hong Kong
Title: ANTL-IGF-IR ANTIBODIES AND USES THEREOF | ANTICORPS ANTI-IGF-IR ET LEURS UTILISATIONS
Usefulness: ANTL-IGF-IR ANTIBODIES AND USES THEREOF | ANTICORPS ANTI-IGF-IR ET LEURS UTILISATIONS
Summary: For treating a tumor or cancer in subject such as human, where the cancer is prostate cancer, breast cancer, liver cancer, or colon cancer (claimed).
Novelty: New isolated antibody that specifically binds to human insulin-like growth factor I receptor, useful for treating tumor or cancer e.g. prostate, breast or liver

Industry

Disease Diagnostic/Treatment

Sub Group

Cancer/Tumor

Application Date

Apr 19, 2004

Application No.

7,189,694

Others

Country/Region

USA

For more information, please click Here